Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

778
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
778
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

12.1K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
12.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Outcomes of Thromboprophylaxis With Apixaban in Patients With Newly Diagnosed Multiple Myeloma, the MyelMeXa Study.

EJHaem·2026
Same author

Outpatient Delivery of Step-Up Doses to Rapidly Initiate Monthly Doses of Bispecific Antibodies in Multiple Myeloma.

European journal of haematology·2026
Same author

Geographic and Socioeconomic Determinants of Treatment Abandonment in Pediatric Acute Leukemia: A Cohort Study in South-Central Mexico.

Cancer control : journal of the Moffitt Cancer Center·2026
Same author

Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexico.

Frontiers in oncology·2025
Same author

Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores.

Research and practice in thrombosis and haemostasis·2024
Same author

Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy.

Frontiers in oncology·2024

Related Experiment Video

Updated: Oct 26, 2025

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.2K

Mexican consensus on Hodgkin's lymphoma.

José L Álvarez-Vera1, Jocelyn Aguilar-Luevano2, Luisa M Alcívar-Cedeño1

  • 1Servicio de Hematología, Centro Médico Nacional 20 de noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Ciudad de México, México.

Gaceta Medica De Mexico
|July 29, 2021
PubMed
Summary

Hodgkin lymphoma (HL) originates from B lymphocytes, characterized by Reed-Sternberg cells and bimodal age distribution. Treatment strategies for HL are tailored based on disease subtype, stage, and prognostic factors.

Keywords:
BrentuximabDeauvilleInmunohistochemicalInmunohistoquímicaQuimioterapiaQuimioterapyReed sternbergReed-Sternberg

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.3K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.5K

Related Experiment Videos

Last Updated: Oct 26, 2025

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.2K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.3K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.5K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Hodgkin lymphoma (HL) is a malignancy arising from B lymphocytes.
  • Pathognomonic Reed-Sternberg cells are a hallmark of HL.
  • HL exhibits a bimodal age distribution, affecting adolescents, young adults, and individuals over 55.

Purpose of the Study:

  • To describe the cellular origin and epidemiological characteristics of Hodgkin lymphoma.
  • To elucidate the gene expression reprogramming in classic Hodgkin lymphoma cells.
  • To outline the factors influencing Hodgkin lymphoma treatment algorithms.

Main Methods:

  • Review of the biological and clinical features of Hodgkin lymphoma.
  • Analysis of gene expression patterns in classic Hodgkin lymphoma cells.
  • Identification of key variables for treatment decision-making.

Main Results:

  • HL arises from clonal transformation of B lymphocytes, producing Reed-Sternberg cells.
  • Classic HL cells undergo significant gene expression reprogramming, losing B-cell markers and acquiring immune cell gene expression.
  • Treatment decisions are complex, influenced by HL subtype, stage, prognostic markers, and disease bulk.

Conclusions:

  • Hodgkin lymphoma is a distinct B-cell malignancy with unique cellular and genetic characteristics.
  • Understanding gene expression reprogramming is crucial for comprehending HL pathogenesis.
  • Personalized treatment approaches are essential for effective Hodgkin lymphoma management.